BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

We estimated the prevalence of and costs associated with genital warts among privately
insured individuals from the perspective of a private health plan in the United States. Health …

External genital warts (EGW) are a sexually transmitted infection caused by various strains
of human papillomavirus (HPV). Several studies have described the direct and indirect costs …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is
also responsible for benign condylomata acuminata, also known as genital warts. We …

Background: Genital warts (GW) are common and increasing in young people. Ninety
percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this …

Abstract Background In the Netherlands, low cervical cancer incidence and mortality rates
might limit the cost-effectiveness of vaccination against the human papillomavirus (HPV). We …

We evaluated the cost‐effectiveness of HPV16/18 vaccination for girls aged 12 years in The
Netherlands in addition to cervical cancer screening. For this purpose, we developed a …

Background Many economic evaluations of human papillomavirus vaccination should
ideally consider multiple disease outcomes, including anogenital warts, respiratory …

Objective: To evaluate the cost-effectiveness and treatment-cost impact of sinecatechins
(Veregen) as first-line therapy against its principal comparator, imiquimod (Aldara), in the …

The quadrivalent human papillomavirus (HPV) vaccine currently being delivered to
Australian women aged 12–26 years under the National HPV Vaccination Program …